🇺🇸 AlvotechALVO
Get Alvotech filings on Telegram the moment they are published.
Follow Alvotech on TelegramOne tap starts your 30-day free trial. No card needed.
Subject: 6-K — Foreign issuer report
Overview: The FDA approved a new manufacturing process for SIMLANDI® (adalimumab-ryvk) that more than doubles drug substance output per batch.
Source: SEC EDGAR · Original filing
Get filings like this in Telegram the moment they are published — for the companies you follow.
Start 30-day trial About Finterest